Daren K. Heyland
10
0
0
6
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 55/100
20.0%
2 terminated/withdrawn out of 10 trials
75.0%
-11.5% vs industry average
20%
2 trials in Phase 3/4
50%
3 of 6 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (10)
A Novel E-health Platform
Role: lead
The RE-ENERGIZE Study: RandomizEd Trial of ENtERal Glutamine to minimIZE Thermal Injury
Role: lead
SodiUm SeleniTe Adminstration IN Cardiac Surgery (SUSTAIN CSX®-Trial).
Role: lead
Canadian Health Advanced By Nutrition and Graded Exercise
Role: lead
Candida in the Respiratory Tract Secretions of Critically Ill Patients and The Efficacy of Antifungal Treatment
Role: lead
Trial of Glutamine and Antioxidant Supplementation in Critically Ill Patients
Role: lead
PERFormance Enhancement of the Canadian Nutrition Guidelines by a Tailored Implementation Strategy: The PERFECTIS Study
Role: lead
Enhanced Protein-Energy Provision Via the Enteral Route in Critically Ill Patients
Role: lead
Realities, Expectations and Attitudes to Life Support Technologies in Intensive Care for Octogenarians:
Role: lead
Advance Care Planning Evaluation in Hospitalized Elderly Patients
Role: lead
All 10 trials loaded